Insmed
Insmed is a biopharmaceutical company dedicated to improving the lives of patients battling serious lung diseases. In 2000, Insmed went public (NASDAQ: INSM).
Insmed operates in biotech based in United States, founded in 1988.
As a business in biotech, Insmed is listed here with the public details available about it.
The company is recorded as being based in United States.
Its current recorded stage is NASDAQ: INSM | Bessemer portfolio company.
| Sector | Biotech |
|---|---|
| Country | United States |
| Founded | 1988 |
| Stage | NASDAQ: INSM | Bessemer portfolio company |
Website: www.insmed.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account